BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34681583)

  • 21. CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma.
    Nishikawa M; Inoue A; Ohnishi T; Yano H; Kanemura Y; Kohno S; Ohue S; Ozaki S; Matsumoto S; Suehiro S; Nakamura Y; Shigekawa S; Watanabe H; Kitazawa R; Tanaka J; Kunieda T
    Cancer Med; 2021 Mar; 10(6):2013-2025. PubMed ID: 33543833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secreted Glioblastoma Nanovesicles Contain Intracellular Signaling Proteins and Active Ras Incorporated in a Farnesylation-dependent Manner.
    Luhtala N; Aslanian A; Yates JR; Hunter T
    J Biol Chem; 2017 Jan; 292(2):611-628. PubMed ID: 27909058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
    Bourguignon LY; Gilad E; Peyrollier K
    J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
    Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC
    Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma.
    Feng C; Zhang Y; Yin J; Li J; Abounader R; Zuo Z
    Neuro Oncol; 2014 Aug; 16(8):1078-85. PubMed ID: 24526308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44.
    Lu YC; Cheng AJ; Lee LY; You GR; Li YL; Chen HY; Chang JT
    Sci Rep; 2017 May; 7(1):2042. PubMed ID: 28515423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells.
    Manzano S; Gutierrez-Uzquiza A; Bragado P; Sequera C; Herranz Ó; Rodrigo-Faus M; Jauregui P; Morgner S; Rubio I; Guerrero C; Porras A
    Cell Death Dis; 2021 Apr; 12(4):348. PubMed ID: 33824275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circ-0001801 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition (EMT) in glioblastoma by regulating miR-628-5p/HMGB3 axis.
    Chen WL; Jiang L; Wang JS; Liao CX
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10874-10885. PubMed ID: 31858556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells.
    Tsubouchi K; Minami K; Hayashi N; Yokoyama Y; Mori S; Yamamoto H; Koizumi M
    J Radiat Res; 2017 Nov; 58(6):816-826. PubMed ID: 29106581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
    Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
    Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation.
    Toulany M; Schickfluss TA; Eicheler W; Kehlbach R; Schittek B; Rodemann HP
    Breast Cancer Res; 2011 Mar; 13(2):R28. PubMed ID: 21392397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of moesin in hyaluronan induced cell migration in glioblastoma multiforme.
    DeSouza LV; Matta A; Karim Z; Mukherjee J; Wang XS; Krakovska O; Zadeh G; Guha A; Siu KM
    Mol Cancer; 2013 Jul; 12():74. PubMed ID: 23855374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells.
    Palumbo S; Tini P; Toscano M; Allavena G; Angeletti F; Manai F; Miracco C; Comincini S; Pirtoli L
    J Cell Physiol; 2014 Nov; 229(11):1863-73. PubMed ID: 24691646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
    Brown DV; Filiz G; Daniel PM; Hollande F; Dworkin S; Amiridis S; Kountouri N; Ng W; Morokoff AP; Mantamadiotis T
    PLoS One; 2017; 12(2):e0172791. PubMed ID: 28241049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma.
    Ma X; Yoshimoto K; Guan Y; Hata N; Mizoguchi M; Sagata N; Murata H; Kuga D; Amano T; Nakamizo A; Sasaki T
    Neuro Oncol; 2012 Sep; 14(9):1153-62. PubMed ID: 22844109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of CD44 in glioblastoma multiforme.
    Mooney KL; Choy W; Sidhu S; Pelargos P; Bui TT; Voth B; Barnette N; Yang I
    J Clin Neurosci; 2016 Dec; 34():1-5. PubMed ID: 27578526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lncRNA RP3-439F8.1 promotes GBM cell proliferation and progression by sponging miR-139-5p to upregulate NR5A2.
    Qi J; Pan L; Yu Z; Ni W
    Pathol Res Pract; 2021 Jul; 223():153319. PubMed ID: 33991848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.
    Fowler A; Thomson D; Giles K; Maleki S; Mreich E; Wheeler H; Leedman P; Biggs M; Cook R; Little N; Robinson B; McDonald K
    Eur J Cancer; 2011 Apr; 47(6):953-63. PubMed ID: 21196113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.